Eli Lilly To Buy German Animal Health Business Lohmann

Law360, New York (February 24, 2014, 6:16 PM EST) -- U.S. pharmaceutical giant Eli Lilly & Co. will acquire German animal vaccine maker Lohmann SE for an undisclosed price in a deal that allows Eli Lilly to further expand its animal vaccine business globally, the company said Monday.

Eli Lilly’s animal health division Elanco has agreed to acquire all assets of the privately held Lohmann SE — which is based in Cuxhaven, Germany — and its subsidiary, Lohmann Animal Health. The assets that Eli Lilly will acquire from Lohmann’s owner PHW Group, which is Germany’s largest...
To view the full article, register now.